GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Dividend Payout Ratio

Caplin Point Laboratories (BOM:524742) Dividend Payout Ratio : 0.00 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Dividend Payout Ratio?

Caplin Point Laboratories's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for Caplin Point Laboratories's Dividend Payout Ratio or its related term are showing as below:

BOM:524742' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.08   Max: 0.16
Current: 0.07


During the past 13 years, the highest Dividend Payout Ratio of Caplin Point Laboratories was 0.16. The lowest was 0.01. And the median was 0.08.

BOM:524742's Dividend Payout Ratio is ranked better than
96.02% of 427 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs BOM:524742: 0.07

As of today (2024-05-25), the Dividend Yield % of Caplin Point Laboratories is 0.35%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Caplin Point Laboratories was 4.26%. The lowest was 0.06%. And the median was 0.49%.

Caplin Point Laboratories's Dividends per Share for the months ended in Mar. 2024 was ₹0.00.

During the past 12 months, Caplin Point Laboratories's average Dividends Per Share Growth Rate was 12.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 124.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 18.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Caplin Point Laboratories was 124.10% per year. The lowest was -35.60% per year. And the median was 23.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Caplin Point Laboratories Dividend Payout Ratio Historical Data

The historical data trend for Caplin Point Laboratories's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Dividend Payout Ratio Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.01 0.08 0.08 0.08

Caplin Point Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.15 0.17 - -

Competitive Comparison of Caplin Point Laboratories's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Dividend Payout Ratio falls into.



Caplin Point Laboratories Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Caplin Point Laboratories's Dividend Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2024 )/ EPS without NRI (A: Mar. 2024 )
=4.5/ 59.9
=0.08

Caplin Point Laboratories's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 16.01
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories (BOM:524742) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Caplin Point Laboratories Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories (BOM:524742) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines